2017
Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS)
Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Internal Medicine 2017, 177: 1471-1479. PMID: 28846767, PMCID: PMC5710212, DOI: 10.1001/jamainternmed.2017.3877.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousAdministration, OralAdultDouble-Blind MethodEstradiolEstrogen Replacement TherapyEstrogensEstrogens, Conjugated (USP)FemaleFollow-Up StudiesGlucuronatesHumansMiddle AgedPostmenopauseProgesteroneProgestinsProspective StudiesPsychiatric Status Rating ScalesQuality of LifeRisk FactorsSexual Dysfunction, PhysiologicalTime FactorsWomen's HealthConceptsKronos Early Estrogen Prevention StudyLow sexual functionTransdermal estrogen therapySexual functionAncillary studiesEstrogen therapyPostmenopausal womenPrevention StudyT-E2Female Sexual Function InventoryOral conjugated equine estrogenOverall scoreLower FSFI scoresEarly postmenopausal womenMenopausal hormone therapyPlacebo-controlled trialOral micronized progesteroneConjugated equine estrogensSexual Function InventoryLast menstrual periodEffects of OralQuality of lifeProportion of womenSymptoms of distressMicronized progesterone
2016
Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders
Erekson EA, Li FY, Martin DK, Fried TR. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause The Journal Of The North American Menopause Society 2016, 23: 368-375. PMID: 26645820, PMCID: PMC4814326, DOI: 10.1097/gme.0000000000000549.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAtrophyDysuriaEmotionsFecal IncontinenceFemaleHumansLife StyleMiddle AgedPelvic Floor DisordersPelvic Organ ProlapsePostmenopauseSexual BehaviorSexual Dysfunction, PhysiologicalSexual Dysfunctions, PsychologicalSurveys and QuestionnairesUrinary Incontinence, UrgeVaginaVaginal DiseasesVulvaVulvar DiseasesConceptsVulvovaginal Symptoms QuestionnairePostmenopausal womenVulvovaginal symptomsPelvic floor disordersSexual impactPrimary care physician's officeUrgency urinary incontinenceSenior centersPrimary care officesPelvic organ prolapsePercent of womenLocal senior centersUrinary frequencyAnal incontinenceSolid stoolUrinary incontinenceCommon symptomsMenopausal symptomsCare officesSymptom questionsOrgan prolapseSymptom questionnaireActive womenPhysician's officeMore symptoms
2013
The Vulvovaginal Symptoms Questionnaire
Erekson EA, Yip SO, Wedderburn TS, Martin DK, Li FY, Choi JN, Kenton KS, Fried TR. The Vulvovaginal Symptoms Questionnaire. Menopause The Journal Of The North American Menopause Society 2013, 20: 973-979. PMID: 23481118, PMCID: PMC3695224, DOI: 10.1097/gme.0b013e318282600b.Peer-Reviewed Original Research